A margetuximab agreement for MacroGenics and EVERSANA
MacroGenics and EVERSANA announce approval-dependent agreement to support launch and commercialization of margetuximab
Disease Focus
eBook
Best of Immuno-oncology
Download DDN’s “Best of Immuno-oncology” ebook to learn more about recent research in cancer immunotherapy. This ebook includes stories about antibody approaches for treating cancer, the potential of CAR-T therapies, precision cancer immunotherapy directed by immune-profiling, and cancer neoepitope discovery.
View eBookBluestar Genomics reports new method for early pancreatic cancer detection
Validation of Bluestar Genomics’ technology for non-invasive detection of pancreatic cancer is published in Nature Communications
View ArticleLatest
Taking cancer care to the next level
OneOncology and Genentech announce a multi-year partnership to improve clinical trials, boost comprehensive genomic profiling
Merck snaps up OncoImmune for $425M
The acquisition nets Merck a pipeline of oncology programs as well as CD24Fc, OncoImmune's lead candidate for the treatment of COVID-19
